6月29日，Hinge Health盘中上涨5.53%，报83.335美元/股，成交额1.3亿美元，延续6月以来强势表现。
消息面上，公司近期在Movement 2026投资者大会上将全年收入指引上调至8.18亿至8.24亿美元，中位数较此前上调2000万美元，远超市场预期的8.02亿美元。同时公司宣布将骨科手术纳入HingeSelect平台，打造覆盖物理治疗、专科评估到术后恢复的全流程肌肉骨骼护理服务。RBC Capital Markets随后将目标价从65美元上调至75美元，维持"跑赢大盘"评级，强调公司20%-25%收入增长及35%以上运营利润率的中期目标"可实现"。此外，公司医学分析显示数字MSK项目每位会员每年节省2941美元，手术量减少69%，进一步验证商业模式价值。
Hinge Health总部位于旧金山，利用AI驱动的护理模式、可穿戴设备和专业临床团队，提供关节和肌肉健康护理的自动化服务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.